NOS Life Sciences Corp.

We have developed a therapeutic that reduces Parkinson's progression by 79%, enhances levodopa motor benefits by 100%, and reduces dyskinesia by 48%.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Málaga, Spain
  • Currency EUR
  • Founded April 2017
  • Employees 7
  • Incorporation Type C-corp
  • Website noslifesciences.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free